Effect of elevated reperfusion pressure on "no reflow" area and infarct size in a porcine model of ischemia-reperfusion

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 21, Issue 4, 2016, Pages 405-411

  Pantsios, Chris ^a   Kapelios, Chris ^a   Vakrou, Styliani ^a   Diakos, Nikolaos ^a   Pozios, Iraklis ^a   Kontogiannis, Chris ^a   Nanas, John ^a   Malliaras, Konstantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Microvascular obstruction; Myocardial infarction; No reflow; Reperfusion injury; Reperfusion pressure

Indexed keywords

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NO REFLOW PHENOMENON; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; ANIMAL; AORTA; ARTERIAL PRESSURE; CARDIAC MUSCLE; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; LIGATION; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NO-REFLOW PHENOMENON; PATHOLOGY; PATHOPHYSIOLOGY; PIG; PROCEDURES; SURGERY; TIME FACTOR; VASCULAR RESISTANCE;

ANIMALS; AORTA; ARTERIAL PRESSURE; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; LIGATION; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NO-REFLOW PHENOMENON; SUS SCROFA; TIME FACTORS; VASCULAR RESISTANCE;

EID: 84978793038     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248415617850     Document Type: Article

References (36)

1. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23): 2909-2945.
2. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3(9):499-506.
3. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26(6):549-557.
4. Weir RA, Murphy CA, Petrie CJ, et al. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3(4):360-367.
5. Reffelmann T, Kloner RA. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006;101(5):359-372.
6. Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55(21):2383-2389.
7. Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res. 2007;74(3):343-355.
8. Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873-882.
9. Lefer AM, Tsao PS, Aoki N, Palladino MA Jr. Mediation of cardioprotection by transforming growth factor-beta. Science. 1990; 249(4964):61-64.
10. Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 1990;82(2):586-594.
11. Duncker DJ, Koller A, Merkus D, Canty JM Jr. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis. 2015;57(5):409-422.
12. Hoffman JIE, Spaan JAE. Pressure-flow relations in coronary circulation. Physiol Rev. 1990;70(2):331-390.
13. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995;92(7):1902-1910.
14. Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 1998; 32(6):1756-1764.
15. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon following temporary coronary occlusion in the dog. J Clin Invest. 1974;54(6):1496-1508.
16. Fishbein MG, Meerbaum S, Rit J, et al. Early phase of acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101(5):593-600.
17. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80(6): 1846-1861.
18. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002;283(3): h1099-h1107.
19. Nanas JN, Tsolakis E, Terrovitis JV, et al. Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest. 2004;125(4):1492-1499.
20. Mozaffari MS, Patel C, Schaffer SW. Mechanisms underlying afterload-induced exacerbation of myocardial infarct size: role of T-type Ca2+ channel. Hypertension. 2006;47(5):912-919.
21. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res. 1963;13:497-500.
22. Goto Y, Slinker BK, LeWinter MM. Effect of coronary hyperemia on Emax and oxygen consumption in blood-perfused rabbit hearts. Energetic consequences of Gregg's phenomenon. Circ Res. 1991;68(2):482-492.
23. Baines CP. How and when do myocytes die during ischemia and reperfusion: the late phase. J Cardiovasc Pharmacol Ther. 2011; 16(3-4):239-243.
24. Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2002; 282(2):h766-h772.
25. Reffelmann T, Kloner RA. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol. 2003;284(4): h1134-h1141.
26. Maekawa K, Kawamoto K, Fuke S, et al. Effects of intraaortic balloon pumping on the angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction. Circ J. 2006;70(1):37-43.
27. Malliaras K, Charitos E, Diakos N, et al. Effects of intra-aortic balloon pump counterpulsation on left ventricular mechanoenergetics in a porcine model of acute ischemic heart failure. J Cardiovasc Transl Res. 2014;7(9):810-820.
28. Amado LC, Kraitchman DL, Gerber BL, et al. Reduction of ''noreflow'' phenomenon by intra-aortic balloon counterpul-sation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol. 2004;43(7):1291-1298
29. Pierrakos CN, Bonios MJ, Drakos SG, et al. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs. 2011;35(9): 867-874.
30. Krivokapich J, Czernin J, Schelbert HR. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol. 1996;28(3): 565-572.
31. Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122(21): 2142-2151.
32. Geeganage CM, Bath PM. Relationship between therapeutic changes in blood pressure and outcomes in acute stroke. A metaregression. Hypertension. 2009;54(4):775-781.
33. Bekkers SC, Yazdani SK, Virmani R, Waltenberger J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol. 2010;55(16):1649-1660.
34. Niccoli G, Lanza GA, Shaw S, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J. 2006; 27(15):1793-1798.
35. Takahashi T, Hiasa Y, Ohara Y, et al. Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. Am J Cardiol. 2007;100(1):35-40.
36. Campo G, Valgimigli M, Gemmati D, et al. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGYStudy. JAmCollCardiol. 2006;48(11):2178-2185.